Better Therapeutics Announces Upcoming Poster Presentation at EASL Congress 2023 in Vienna, Austria
Naim Alkhouri, MD, FAASLD, to Present Findings from Non-alcohol Related Fatty Liver Disease Feasibility StudySAN FRANCISCO--(BUSINESS WIRE)--$BTTX #digitalhealth--Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing a clinically validated, software-based, novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases, today announced…